Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;48:1012-1017
Published online before print October 23, 2006, doi: 10.1161/01.HYP.0000249510.20326.72
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/6/1012    most recent
01.HYP.0000249510.20326.72v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feihl, F.
Right arrow Articles by Levy, B. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feihl, F.
Right arrow Articles by Levy, B. I.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Blood Pressure Medicines
*High Blood Pressure
Related Collections
Right arrow Remodeling
Right arrow ACE/Angiotension receptors
Right arrow Angiogenesis
Right arrow Hypertrophy
Right arrow Clinical Studies
Right arrow Other Vascular biology

(Hypertension. 2006;48:1012.)
© 2006 American Heart Association, Inc.


Brief Reviews

Hypertension

A Disease of the Microcirculation?

François Feihl; Lucas Liaudet; Bernard Waeber; Bernard I. Levy

From the Division de Physiopathologie Clinique (F.F., B.W.), Département de Médecine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Service de Médecine Intensive Adulte (L.L.), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre de Recherche Cardiovasculaire de Lariboisière (B.I.L.), Unité Inserm 689, Hôpital Lariboisière, Paris, France.

Correspondence to François Feihl, PPA, BH10-701, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. E-mail Francois.Feihl@chuv.ch


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
In the last decade, the pathophysiology of microcirculation has become an actively developing field of hypertension research, which we have felt it useful to review. An exact definition of microcirculation is elusive. It is often taken morphologically, to encompass all of the blood vessels with a diameter <150 µm, that is, some small arteries, arterioles, capillaries, and venules,1 with the morphological distinction between small arteries and arterioles not entirely clear, because some2 but not all authors3 limit the concept of arteriole to vessels containing a single layer of smooth muscle cells. Functionally, it is usually accepted that the arterial side of the microcirculation composes most of the resistance vessels, meaning that the largest part of the pressure drop between large conduit arteries and veins takes place in this segment.2,4 The "resistance" property of small arteries and arterioles is intimately, although not exclusively, related to the prevalence of myogenic tone in these vessels.5,6

Myogenic tone is an intrinsic property of vascular smooth muscle, which contracts in response to stretching, independent of any nerve or humoral mediation.5 All arteries have myogenic tone and, therefore, contract in response to an increase in blood pressure. Myogenic tone gains in importance with decreasing vessel caliber,7,8 and only in small arteries and arterioles (diameter: 15 to 300 µm, depending on species and organ) can it provoke substantial luminal narrowing (or even closure) in reaction to an increase in transmural pressure.8,9 In the hamster cheek pouch, for example, control of arterial/arteriolar luminal size by myogenic tone seems . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Exp PhysiolHome page
P. E. Gates, W. D. Strain, and A. C. Shore
Human endothelial function and microvascular ageing
Exp Physiol, March 1, 2009; 94(3): 311 - 316.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
B. I. Levy
Blood pressure as a potential biomarker of the efficacy angiogenesis inhibitor
Ann. Onc., February 1, 2009; 20(2): 200 - 203.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Vilar, L. Waeckel, P. Bonnin, C. Cochain, C. Loinard, M. Duriez, J.-S. Silvestre, and B. I. Levy
Chronic Hypoxia-Induced Angiogenesis Normalizes Blood Pressure in Spontaneously Hypertensive Rats
Circ. Res., September 26, 2008; 103(7): 761 - 769.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. I. Levy, E. L. Schiffrin, J.-J. Mourad, D. Agostini, E. Vicaut, M. E. Safar, and H. A.J. Struijker-Boudier
Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus
Circulation, August 26, 2008; 118(9): 968 - 976.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. I. Levy
Commentary on Viewpoint: The human cutaneous circulation as a model of generalized microvascular function
J Appl Physiol, July 1, 2008; 105(1): 380 - 380.
[Full Text] [PDF]


Home page
HypertensionHome page
D. You, C. Cochain, C. Loinard, J. Vilar, B. Mees, M. Duriez, B. I. Levy, and J.-S. Silvestre
Hypertension Impairs Postnatal Vasculogenesis: Role of Antihypertensive Agents
Hypertension, June 1, 2008; 51(6): 1537 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J.-J. Mourad, G. des Guetz, H. Debbabi, and B. I. Levy
Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
Ann. Onc., May 1, 2008; 19(5): 927 - 934.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Feihl, L. Liaudet, B. I. Levy, and B. Waeber
Hypertension and microvascular remodelling
Cardiovasc Res, May 1, 2008; 78(2): 274 - 285.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
C. Cheng, C. Daskalakis, and B. Falkner
Original Research: Capillary rarefaction in treated and untreated hypertensive subjects
Therapeutic Advances in Cardiovascular Disease, April 1, 2008; 2(2): 79 - 88.
[Abstract] [PDF]